Reducing central nervous system complications associated with the human immunodeficiency virus

Affiliations

Comment

D Mclauchlan et al. J Neurol. 2014 Sep.

. 2014 Sep;261(9):1842-5.

doi: 10.1007/s00415-014-7466-9.

¹ Department of Neurology, Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK.

No abstract available

Comment on

HIV-Associated Central Nervous System Disease in Patients Admitted at the Douala General Hospital between 2004 and 2009: A Retrospective Study.
Luma HN, Tchaleu BC, Temfack E, Doualla MS, Ndenga DP, Mapoure YN, Njamnshi AK, Djientcheu VD. Luma HN, et al. AIDS Res Treat. 2013;2013:709810. doi: 10.1155/2013/709810. Epub 2013 Feb 26. AIDS Res Treat. 2013. PMID: 23533732 Free PMC article.
Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions.
Caniglia EC, Cain LE, Justice A, Tate J, Logan R, Sabin C, Winston A, van Sighem A, Miro JM, Podzamczer D, Olson A, Arribas JR, Moreno S, Meyer L, del Romero J, Dabis F, Bucher HC, Wandeler G, Vourli G, Skoutelis A, Lanoy E, Gasnault J, Costagliola D, Hernán MA; HIV-CAUSAL Collaboration. Caniglia EC, et al. Neurology. 2014 Jul 8;83(2):134-41. doi: 10.1212/WNL.0000000000000564. Epub 2014 Jun 6. Neurology. 2014. PMID: 24907236 Free PMC article.
Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
Boulware DR, Meya DB, Muzoora C, Rolfes MA, Huppler Hullsiek K, Musubire A, Taseera K, Nabeta HW, Schutz C, Williams DA, Rajasingham R, Rhein J, Thienemann F, Lo MW, Nielsen K, Bergemann TL, Kambugu A, Manabe YC, Janoff EN, Bohjanen PR, Meintjes G; COAT Trial Team. Boulware DR, et al. N Engl J Med. 2014 Jun 26;370(26):2487-98. doi: 10.1056/NEJMoa1312884. N Engl J Med. 2014. PMID: 24963568 Free PMC article. Clinical Trial.